Advertisement
Screener

ARVINAS, INC. (ARVN) Material Contracts

ARVINAS, INC. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-04: Form 10-Q; Exhibit 10.4; Description Consulting Agreement, dated June 6, 2025, by and between Arvinas Operations, Inc. and Ian Taylor, Ph.D., as amended June 13, 2025 and May 14, 2026..
  • 2026-08-04: Form 10-Q; Exhibit 10.3; Description Separation Agreement, dated June 22, 2026, by and between Arvinas, Inc. and Noah Berkowitz, M.D., Ph.D..
  • 2026-08-04: Form 10-Q; Exhibit 10.2; Description Letter Agreement, dated May 11, 2026, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer Inc..
  • 2026-08-04: Form 10-Q; Exhibit 10.1; Description License Agreement, dated May 11, 2026, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc., Pfizer Inc., and Rigel Pharmaceuticals, Inc..
FiledFormExhibitDescription
2026-08-0410-Q10.4Consulting Agreement, dated June 6, 2025, by and between Arvinas Operations, Inc. and Ian Taylor, Ph.D., as amended June 13, 2025 and May 14, 2026.
2026-08-0410-Q10.3Separation Agreement, dated June 22, 2026, by and between Arvinas, Inc. and Noah Berkowitz, M.D., Ph.D.
2026-08-0410-Q10.2Letter Agreement, dated May 11, 2026, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer Inc.
2026-08-0410-Q10.1License Agreement, dated May 11, 2026, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc., Pfizer Inc., and Rigel Pharmaceuticals, Inc.
2026-02-2410-K10.18Consulting Agreement, dated February 12, 2026, by and between Arvinas, Inc. and John Houston, Ph.D.
2026-02-2410-K10.16Amended and Restated Employment Agreement, dated February 12, 2026, by and between the Registrant and Randy Teel, Ph.D.
2026-02-2410-K10.8Form of Restricted Stock Unit Agreement under 2018 Stock Incentive Plan.
2025-11-0510-Q10.2Amended and Restated Employment Agreement, dated November 4, 2025, by and between the Registrant and Randy Teel, Ph.D.
2025-11-0510-Q10.1Amended and Restated Employment Agreement, dated November 4, 2025, by and between the Registrant and Angela Cacace, Ph.D.
2025-08-0610-Q10.1Consulting Agreement, dated June 6, 2025, by and between Arvinas Operations, Inc. and Ian Taylor, Ph.D.
2025-02-1110-K10.31Lease Termination Agreement between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated January 15, 2025.
2025-02-1110-K10.30Third Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated December 13, 2024.
2025-02-1110-K10.26Ninth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated February 10, 2025.
2025-02-1110-K10.25Eighth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated December 31, 2024.
2025-02-1110-K10.24Seventh Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated December 13, 2024.
2024-10-3010-Q10.1Lease Termination Agreement, dated August 15, 2024, by and among Arvinas Operations, Inc. and 101 College Street, LLC.
2024-07-3010-Q10.6Amended and Restated License Agreement, by and between Yale University and Arvinas Operations, Inc., dated June 18, 2024.
2024-07-3010-Q10.5Asset Purchase Agreement by and among Arvinas, Inc., Arvinas Operations, Inc., Arvinas Androgen Receptor, Inc. and Novartis Pharma AG, dated April 10, 2024.
2024-07-3010-Q10.4License Agreement by and among Arvinas, Inc., Arvinas Operations, Inc., Arvinas Androgen Receptor, Inc. and Novartis Pharma AG, dated April 10, 2024.
2024-07-3010-Q10.2Promotion Letter for Angela Cacace, Ph.D., dated July 8, 2024.
2024-07-3010-Q10.1Employment Agreement between the Registrant and Andrew Saik, dated June 17, 2024.
2024-05-0710-Q10.3Second Amendment to Lease between 101 College Street, LLC and Arvinas Operations, Inc., dated December 20, 2023.
2024-05-0710-Q10.2Promotion Letter for Randy Teel, Ph.D., dated April 21, 2024.
2024-05-0710-Q10.1Employment Agreement between the Registrant and Noah Berkowitz, M.D., Ph.D. dated March 18, 2024.
2023-11-278-K10.2Registration Rights Agreement, dated November 24, 2023, by and among the Company and the other parties thereto.
2023-11-278-K10.1Securities Purchase Agreement, dated November 24, 2023, by and among the Company and the other parties thereto.
2023-08-0810-Q10.2First Amendment to Collaboration and License Agreement between Arvinas Operations, Inc. and Bayer AG, dated June 30, 2023
2023-08-0810-Q10.1Sixth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated June 13, 2023
2023-02-2310-K10.34Amended and Restated IP Contribution Agreement between Arvinas Operations, Inc. and Oerth Bio LLC f/k/a Protag LLC, effective December 20, 2022.
2023-02-2310-K10.32Amendment No. 3 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc (formerly Arvinas, Inc.), dated December 21, 2022
2022-11-0910-Q10.1First Amendment to Lease between 101 College Street, LLC and Arvinas Operations, Inc., dated August 5, 2022.
2022-08-0410-Q10.1Master In Vitro Diagnostics Agreement between Foundation Medicine, Inc and Arvinas Operations, Inc. dated June 4, 2022.
2022-05-0510-Q10.2Form of Restricted Stock Unit Agreement under 2018 Stock Incentive Plan
2022-05-0510-Q10.1Amendment No. 2 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated January 14, 2022
2021-08-0510-Q10.1Lease between 101 College Street, LLC and Arvinas Operations, Inc., dated May 4, 2021.
2021-07-228-K10.3Investor Agreement, dated July 21, 2021, by and between Arvinas, Inc. and Pfizer, Inc.
2021-07-228-K10.2Stock Purchase Agreement, dated July 21, 2021, by and between Arvinas, Inc. and Pfizer, Inc.
2021-07-228-K10.1Collaboration Agreement, dated July 21, 2021, by and between Arvinas, Inc., Arvinas Operations, Inc., Arvinas Estrogen Receptor, Inc. and Pfizer, Inc.
2021-03-0110-K10.35Second Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated January 4, 2021.
2021-03-0110-K10.34Fifth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated January 4, 2021.
2020-04-2810-Q10.1Employment Agreement between the Registrant and Ronald Peck, M.D., dated July 18, 2019.
2020-03-1610-K10.24Amendment No. 1 to Research Collaboration and License Agreement between Pfizer Inc. and Arvinas Operations, Inc. (formerly Arvinas, Inc.), dated December 9, 2019.
2020-03-1610-K10.16First Amendment to Lease between Arvinas Operations, Inc. and Science Park Development Corporation, dated February 27, 2020.
2020-03-1610-K10.15Lease Agreement between Arvinas Operations, Inc. and Science Park Development Corporation, dated November 15, 2019.
2020-03-1610-K10.14Fourth Amendment to Lease between Arvinas Operations, Inc. (formerly Arvinas, Inc.) and Science Park Development Corporation, dated January 31, 2020.
2019-08-0510-Q10.7Amendment No. 5 to License Agreement between Yale University and Arvinas Operations, Inc. (formerly Arvinas, Inc.) dated June 3, 2019.
2019-08-0510-Q10.6Investor Agreement between the Registrant and Bayer AG, dated July 16, 2019.
2019-08-0510-Q10.5Stock Purchase Agreement between the Registrant and Bayer AG, dated June 3, 2019.
2019-08-0510-Q10.4Arvinas IP Contribution Agreement Agreement between Arvinas Operations, Inc. and Protag LLC, dated July 16, 2019.
2019-08-0510-Q10.3Option Agreement between Arvinas Operations, Inc. and Bayer CropScience LP, dated June 3, 2019.
2019-08-0510-Q10.2Commitment Agreement between Arvinas Operations, Inc., Protag LLC, and Bayer CropScience LP, dated June 3, 2019.
2019-08-0510-Q10.1Collaboration and License Agreement between Arvinas Operations, Inc. and Bayer AG, dated June 3, 2019.
2019-03-2610-K10.16Amendment No. 4 to License Agreement between Yale University and Arvinas Operations, Inc. (formerly Arvinas, Inc.) dated January 9, 2019.
2019-03-2610-K10.6Form of Restricted Stock Unit Agreement under 2018 Stock Incentive Plan.
2019-03-158-K10.1Third Amendment to Lease, dated March 12, 2019, by and between Arvinas Operations, Inc. and Science Park Development Corporation

Similar stocks

Stock NameCountryMarket CapPE Ratio
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
Evolus, Inc. (EOLS)United States$0.519B-13.32
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Ovid Therapeutics Inc. (OVID)United States$0.487B-14.41
Indaptus Therapeutics, Inc. (INDP)United States$0.537B
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85